Guild ups opposition to TGA’s codeine decision
The Pharmacy Guild is ramping up its opposition to the decision by the Therapeutic Goods Administration to make medications containing codeine available on a prescription-only basis.
In December, the TGA announced that all products containing codeine would be at least S4 from February 2018.
But the Guild says this will simply add to overall healthcare costs, and do little to address the misuse of these products by some patients.
National president George Tambassis (pictured) told Pharmacy News the move was “short-sighted and ultimately would only add pressure to the already financially stressed health system while also increasing the burden on already over-worked doctors”.
Mr Tambassis said patients would have to consult their GP every time they needed these products. “It will limit access to these medicines for people with genuine medical needs.”
He warned it was now